HK1210591A1 - High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms - Google Patents

High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Info

Publication number
HK1210591A1
HK1210591A1 HK15111340.7A HK15111340A HK1210591A1 HK 1210591 A1 HK1210591 A1 HK 1210591A1 HK 15111340 A HK15111340 A HK 15111340A HK 1210591 A1 HK1210591 A1 HK 1210591A1
Authority
HK
Hong Kong
Prior art keywords
preparation
dosage forms
solid dosage
high content
preparing non
Prior art date
Application number
HK15111340.7A
Other languages
Chinese (zh)
Inventor
.布頓
.蘭貝思
.利馬塔
帕特里克.
.胡
Original Assignee
Si Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49841833&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1210591(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/714,768 external-priority patent/US9629809B2/en
Application filed by Si Group Inc filed Critical Si Group Inc
Publication of HK1210591A1 publication Critical patent/HK1210591A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
HK15111340.7A 2012-12-14 2015-11-17 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms HK1210591A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/714,768 US9629809B2 (en) 2008-07-21 2012-12-14 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
PCT/US2013/072981 WO2014093073A1 (en) 2012-12-14 2013-12-04 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Publications (1)

Publication Number Publication Date
HK1210591A1 true HK1210591A1 (en) 2016-04-29

Family

ID=49841833

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111340.7A HK1210591A1 (en) 2012-12-14 2015-11-17 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Country Status (9)

Country Link
EP (1) EP2931261A1 (en)
JP (1) JP6285952B2 (en)
CN (1) CN104884048B (en)
BR (1) BR112015013945A8 (en)
CA (1) CA2894272A1 (en)
CL (1) CL2015001621A1 (en)
HK (1) HK1210591A1 (en)
MX (1) MX2015007571A (en)
WO (1) WO2014093073A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111194211B (en) 2017-08-31 2023-06-16 诺华股份有限公司 Method for preparing granules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293764B1 (en) * 1997-07-23 1999-03-10 Chiesi Farma Spa PHARMACEUTICAL COMPOSITIONS IN THE FORM OF EFFERVESCENT TABLETS CONTAINING AN UNSTABLE ACTIVE IN THE PRESENCE OF WATER
JP4753567B2 (en) * 2004-11-19 2011-08-24 旭化成ケミカルズ株式会社 Method for producing tablet containing highly adhesive drug
DE102005009241A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with controlled bioavailability
CN102099017A (en) * 2008-07-21 2011-06-15 雅宝公司 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CA2794171C (en) * 2010-03-24 2018-07-03 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

Also Published As

Publication number Publication date
JP2016508124A (en) 2016-03-17
WO2014093073A1 (en) 2014-06-19
CN104884048B (en) 2018-11-23
MX2015007571A (en) 2016-04-15
CA2894272A1 (en) 2014-06-19
BR112015013945A2 (en) 2017-07-11
JP6285952B2 (en) 2018-02-28
BR112015013945A8 (en) 2019-10-08
EP2931261A1 (en) 2015-10-21
CN104884048A (en) 2015-09-02
CL2015001621A1 (en) 2015-08-07

Similar Documents

Publication Publication Date Title
IL285390A (en) Arylquinazolines, their preparation and pharmaceutical compositions containing them
HRP20181172T1 (en) 4-position substituted pyrazolopyrimidine derivative, and use thereof in drug preparation
IL231382A0 (en) Benzonitrile derivatives, their preparation and medicines containing them
IL231386A0 (en) Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
EP2881395A4 (en) Piperazinotrizole compound, preparation method therefor, and use thereof in drug preparation
IL235414A (en) Pyrrolotriazinone derivatives, their preparation and pharmaceutical compositions containing them
PL2655375T3 (en) Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
HK1222563A1 (en) Pharmaceutical composition, preparation and uses thereof
EP2939662A4 (en) Pharmaceutical composition with improved stability, containing temozolomide, and preparation method therefor
IL233602A (en) Benzamide derivatives, their preparation and pharmaceutical compositions containing them
SG11201602935PA (en) Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
IL237322A0 (en) Solid pharmaceutical compositions containing levothyroxine and their preparation
IL233825A (en) 1h-indazole-3-carboxamide compounds, compositions comprising them and uses thereof in the preparation of medicaments
EP2924042A4 (en) Bis- -carboline compound and preparation method, pharmaceutical composition and use thereof
EP2865666A4 (en) Hexahydropentaleno derivatives, preparation method and use in medicine thereof
HK1211570A1 (en) Indene derivatives, their preparation and use as medicaments
IL246297A0 (en) Pyrazine derivatives, their preparation and pharmaceutical compositions containing them
HK1210591A1 (en) High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
HK1204613A1 (en) Substituted pyrano and furanoquinolines, their preparation and use as medicaments
EP2926811A4 (en) Artemether-containing pharmaceutical composition, preparation, and use thereof
EP2844661A4 (en) Heterocycle-fused morphinans, use thereof and preparation thereof
IL284405A (en) Pharmaceutical composition, preparation and uses thereof
IL236870A0 (en) Hydroxystatin derivatives, their preparation and pharmaceutical compositions containing them
EP2882801C0 (en) Conductive polymeric materials, preparation and use thereof
HK1201179A1 (en) Antacid tablet